Adaptimmune(ADAP) - 2019 Q2 - Earnings Call Transcript

Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2019 Results Conference Call August 1, 2019 8:00 AM ET Company Participants Juli Miller - IR James Noble - CEO Adrian Rawcliffe - Incoming CEO Rafael Amado - President, R&D Conference Call Participants Waleed Abdel-Naby - SunTrust Robinson Humphrey Kelsey Goodwin - Guggenheim Securities Marc Frahm - Cowen Keith Tapper - Citi Jonathan Chang - SVB Leerink Jim Birchenough - Wells Fargo Tony Butler - Roth Capital Partners Operator Good morning, and welcome to the Se ...